STOCK TITAN

Sight Sciences (SGHT) COO sells 12,728 shares to cover RSU tax obligations

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Sight Sciences, Inc. Chief Operating Officer Alison Bauerlein reported a sale of 12,728 shares of Common Stock on May 18, 2026 at a weighted average price of $5.12 per share. According to the disclosure, these shares were sold to cover her tax liability arising from recently vested restricted stock units.

After this tax-related sale, Bauerlein directly holds 688,893 shares, which includes 169,810 shares of Common Stock and 519,083 shares that are scheduled to be issued as her remaining RSUs vest and settle over time.

Positive

  • None.

Negative

  • None.

Insights

COO’s sale is a routine tax-related disposition tied to RSU vesting.

COO Alison Bauerlein sold 12,728 shares of Sight Sciences Common Stock at a weighted average of $5.12 per share. Footnote language states the sale was made to cover tax liabilities from vesting restricted stock units, a common administrative step in equity compensation.

Following the transaction, she reports 688,893 shares, including 519,083 shares that will be issued upon future RSU vesting. The sold amount is small relative to her reported position, and the filing frames it as tax-driven rather than a discretionary portfolio change.

Insider Bauerlein Alison
Role Chief Operating Officer
Sold 12,728 shs ($65K)
Type Security Shares Price Value
Sale Common Stock 12,728 $5.12 $65K
Holdings After Transaction: Common Stock — 688,893 shares (Direct, null)
Footnotes (1)
  1. Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs"). Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $4.91 to $5.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Includes (i) 169,810 shares of Common Stock, and (ii) 519,083 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested.
Shares sold 12,728 shares Common Stock sold on May 18, 2026
Weighted average sale price $5.12 per share Open-market sale price for 12,728 shares
Sale price range $4.91–$5.20 per share Prices of multiple sale transactions
Shares owned after transaction 688,893 shares Total reported beneficial ownership following sale
Current Common Stock holdings 169,810 shares Portion of post-transaction holdings in issued stock
Unvested RSU-related shares 519,083 shares Shares to be acquired upon RSU vesting and settlement
restricted stock units financial
"in connection with the vesting of restricted stock units ("RSUs")."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
weighted average price financial
"Reflects the weighted average price at which the shares of Common Stock were sold."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Common Stock financial
"shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
beneficial ownership financial
"Includes (i) 169,810 shares of Common Stock, and (ii) 519,083 shares of Common Stock which shall be acquired"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Bauerlein Alison

(Last)(First)(Middle)
C/O SIGHT SCIENCES, INC.
4040 CAMPBELL AVE., SUITE 100

(Street)
MENLO PARK CALIFORNIA 94025

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Sight Sciences, Inc. [ SGHT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Operating Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/18/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/18/2026S12,728(1)D$5.12(2)688,893(3)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs").
2. Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $4.91 to $5.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. Includes (i) 169,810 shares of Common Stock, and (ii) 519,083 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested.
/s/Jeremy Hayden, Attorney-in-Fact for Alison Bauerlein05/19/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Sight Sciences (SGHT) COO Alison Bauerlein report in this Form 4?

Alison Bauerlein reported selling 12,728 shares of Sight Sciences Common Stock. The sale was described as covering tax liabilities arising from the vesting of restricted stock units, rather than a discretionary open-market portfolio adjustment.

How many Sight Sciences (SGHT) shares did the COO sell and at what price?

She sold 12,728 shares of Common Stock at a weighted average price of $5.12 per share. Footnotes note the sales occurred in multiple trades within a price range from $4.91 to $5.20 per share.

Why were the SGHT shares sold by the COO according to the disclosure?

The filing states the shares were sold to cover the reporting person’s tax liability related to vesting restricted stock units. This indicates the transaction was tied to compensation-related tax obligations rather than a standalone investment decision.

What is Alison Bauerlein’s reported SGHT share position after this transaction?

After the sale, she reports beneficial ownership of 688,893 shares. This total includes 169,810 shares of Common Stock and 519,083 additional shares that will be issued as her already-granted restricted stock units vest and settle in the future.

How were the sale prices for the SGHT shares distributed?

The Form 4 notes the reported $5.12 figure is a weighted average sale price. Individual trades occurred in multiple transactions at prices ranging from $4.91 to $5.20 per share, as detailed in a descriptive footnote.

Does this SGHT Form 4 mention remaining unvested RSUs for the COO?

Yes. A footnote explains that her holdings include 519,083 shares of Common Stock that will be acquired upon the vesting and settlement of restricted stock units that have not yet vested, highlighting significant ongoing equity-based compensation.